The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Addressing underrecognized symptoms and quality-of-life issues in hematologic malignancies
Esther Oliva, MD, London North West University Healthcare NHS Trust, London, UK, discusses underappreciated issues in hematological malignancies, including fatigue, sleep disturbance, emotional distress, and social isolation, which can impact patients’ quality of life. Dr Oliva highlights the importance of direct patient reporting and the need to measure patient experience with the same seriousness as laboratory and survival endpoints. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
